About Rebiotix
Rebiotix is a company based in Roseville (United States) founded in 2011 was acquired by Ferring Pharmaceuticals in April 2018.. Rebiotix has raised $29.3 million across 3 funding rounds from investors including Ferring Pharmaceuticals. Rebiotix offers products and services including Donor Program. Rebiotix operates in a competitive market with competitors including Novozymes, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
- Headquarter Roseville, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rebiotix Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$29.3 M (USD)
in 3 rounds
-
Latest Funding Round
$8.52 M (USD), Series B
Sep 05, 2017
- Investors
-
Employee Count
Employee Count
-
Acquired by
Ferring Pharmaceuticals
(Apr 05, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rebiotix
Rebiotix offers a comprehensive portfolio of products and services, including Donor Program. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Program for donor-related activities in pharmaceuticals context.
Unlock access to complete
Funding Insights of Rebiotix
Rebiotix has successfully raised a total of $29.3M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $8.52 million completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $8.5M
-
First Round
First Round
(04 Nov 2011)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2017 | Amount | Series B - Rebiotix | Valuation |
investors |
|
| Jul, 2014 | Amount | Series B - Rebiotix | Valuation |
investors |
|
| Nov, 2011 | Amount | Seed - Rebiotix | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rebiotix
Rebiotix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ferring Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of drugs in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rebiotix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rebiotix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rebiotix Comparisons
Competitors of Rebiotix
Rebiotix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novozymes, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
|
| domain | founded_year | HQ Location |
Prophylactic vaccines for infectious diseases are developed and advanced.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rebiotix
Frequently Asked Questions about Rebiotix
When was Rebiotix founded?
Rebiotix was founded in 2011.
Where is Rebiotix located?
Rebiotix is headquartered in Roseville, United States. It is registered at Roseville, California, United States.
Is Rebiotix a funded company?
Rebiotix is a funded company, having raised a total of $29.3M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.78M, raised on Nov 04, 2011.
What does Rebiotix do?
Rebiotix was founded in 2011 and is headquartered in Roseville, United States. Biologic drugs are developed by the company for gastrointestinal diseases, with a focus on recurrent Clostridium difficile infections through microbiome-based approaches. RBX2660, a microbiota suspension derived from fecal transplants, is advanced as a primary therapy. Additional efforts target ulcerative colitis and metabolic syndrome within the biotechnology sector.
Who are the top competitors of Rebiotix?
Rebiotix's top competitors include Novozymes, Vaxcyte and Serum Institute of India.
What products or services does Rebiotix offer?
Rebiotix offers Donor Program.
Who are Rebiotix's investors?
Rebiotix has 1 investor. Key investors include Ferring Pharmaceuticals.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.